Hervé Affagard, CEO and co-founder of MaaT Pharma, traded industrial engineering for medicine after cancer struck his family. Now, he’s pioneering microbiome-based therapies to restore balance in the gut, boost immunity, and tackle diseases from graft-versus-host to cancer itself. On Behind the Breakthroughs, Hervé shares how reimagining our inner ecosystem could transform treatment.

Want me to make this one lean even harder into the industrial-to-biotech transformation angle for extra contrast?

Produced and hosted by Jonathan D. Grinstein, PhD

Audio mixed and mastered by David Mosely

Brought to you by Inside Precision Medicine (SAGE Publishing)

Hosted on Acast. See acast.com/privacy for more information.